Advertisement
Loading...

Pfizer Inc.

PFENYSE
Healthcare
Drug Manufacturers - General
$25.33
$-0.42(-1.63%)
U.S. Market opens in 27h 1m

Pfizer Inc. (PFE) Stock Overview

Explore Pfizer Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap144.4B
P/E Ratio19.21
EPS (TTM)$1.31
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$25.57
3 Months$28.17
1 Year Target$26.26

PFE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pfizer Inc. (PFE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 32.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $26.26.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.21 and a market capitalization of 144.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.63%
5-Day Change
-3.17%
1-Month Change
-6.84%
3-Month Change
-8.16%
6-Month Change
1.08%
Year-to-Date (YTD) Change
1.73%
1-Year Change
12.08%
3-Year Change
-31.84%
5-Year Change
-36.85%
All-Time (Max) Change
5797.14%

Contact Information

212 733 2323
66 Hudson Boulevard East, New York City, NY, 10001-2192

Company Facts

81,000 Employees
IPO DateJun 1, 1972
CountryUS
Actively Trading

Frequently Asked Questions